Our Pricing

What Is Mounjaro and How Can Hove Residents Access It?

Published: 30 September 2026

Residents searching for Mounjaro Hove services can access this prescription weight loss treatment through Cured Pharmacy, a fully registered UK online pharmacy serving the Hove area with genuine tirzepatide injections from £124.99. Mounjaro (tirzepatide) is an MHRA-licensed medication that works by activating GLP-1 and GIP receptors to reduce appetite and improve blood sugar control, helping eligible patients achieve significant weight loss when combined with lifestyle changes [1]. All prescriptions require a free online consultation with our UK-registered clinical team, with discreet delivery directly to your Hove address.

How Mounjaro Works for Hove Patients Seeking Weight Loss

Mounjaro Hove patients benefit from tirzepatide's dual-action mechanism, which targets both GLP-1 and GIP receptors to suppress appetite, slow gastric emptying, and enhance insulin sensitivity [1]. Clinical trials demonstrated that participants using tirzepatide achieved average weight reductions of up to 22.5% of their body weight over 72 weeks, significantly outperforming placebo groups [2]. This makes Mounjaro one of the most effective prescription weight loss treatments currently available in the UK.

For Hove residents considering Mounjaro, the treatment involves weekly subcutaneous injections using a pre-filled KwikPen device. The dosing schedule begins at 2.5mg for four weeks to minimise side effects, then gradually increases to a maintenance dose of 5mg, 10mg, or 15mg depending on individual response and tolerability [3]. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures every prescription is clinically appropriate and tailored to each patient's medical history.

Eligibility Criteria for Mounjaro Hove Prescriptions

To receive a Mounjaro Hove prescription through Cured Pharmacy, patients must meet specific clinical criteria established by NICE and MHRA guidance. Eligible individuals typically have a BMI of 30 or above, or a BMI of 27 or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [4]. Our online consultation assesses your medical history, current medications, and contraindications to ensure safe prescribing.

Mounjaro is not suitable for everyone. Hove patients with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or diabetic retinopathy should not use tirzepatide [3]. Pregnant or breastfeeding individuals are also excluded. Our UK-registered prescribers carefully review each application to confirm suitability before approving treatment.

Mounjaro Hove Assessment Process

The Cured Pharmacy consultation for Mounjaro Hove residents takes under three minutes to complete online. You'll answer questions about your weight history, existing health conditions, previous weight loss attempts, and current medications. Our clinical team reviews your responses within hours, and if approved, your prescription is dispatched with next-day delivery options available across the Hove area. All packaging is 100% discreet with no external branding.

Mounjaro Hove Pricing and Transparent Cost Structure

Cured Pharmacy offers Mounjaro Hove patients the lowest UK pricing guaranteed, starting at £124.99 per month. Unlike many competitors, we display all costs upfront before you begin your consultation, with no hidden fees or surprise charges. New patients can Save £20 on their first order using code Weightlossnew, reducing the initial cost to £124.99.

Our transparent pricing structure includes the medication, clinical consultation, prescription review, and discreet home delivery to your Hove address. We never charge additional consultation fees or subscription costs. Each KwikPen contains four weeks of treatment, and our team provides ongoing support throughout your weight loss journey at no extra charge.

Clinical Evidence Supporting Mounjaro for Hove Weight Loss Patients

The SURPASS clinical trial programme provides robust evidence for Mounjaro's efficacy in weight management. In the SURPASS-1 trial, participants receiving 15mg tirzepatide weekly lost an average of 9.5kg over 40 weeks compared to placebo [2]. The SURPASS-2 study demonstrated superior weight loss with tirzepatide versus semaglutide 1mg, with participants achieving 12.4kg average reduction at the highest dose [5].

For Mounjaro Hove patients, these trial results translate to realistic expectations when combined with dietary modifications and increased physical activity. Approximately 89% of participants in clinical studies achieved at least 5% body weight reduction, and 50% achieved 15% or greater weight loss [2]. Individual results vary based on adherence, baseline weight, metabolic factors, and lifestyle commitment.

Real-World Outcomes for Mounjaro Hove Users

Beyond controlled trials, real-world data from UK prescribing patterns shows that Mounjaro Hove patients who maintain consistent weekly injections and follow nutritional guidance achieve meaningful, sustained weight loss. Most individuals notice appetite suppression within the first two weeks, with progressive weight reduction becoming evident from week four onwards. Our clinical team monitors progress through follow-up consultations to optimise dosing and address any concerns.

Managing Side Effects of Mounjaro in Hove Patients

Common side effects reported by Mounjaro Hove users include nausea, diarrhoea, vomiting, constipation, and abdominal discomfort, particularly during dose escalation phases [3]. These gastrointestinal symptoms are typically mild to moderate and diminish as the body adjusts to treatment. Starting at the lowest 2.5mg dose and gradually titrating upwards significantly reduces the incidence and severity of these effects.

Hove residents experiencing persistent or severe side effects should contact our clinical team immediately. Rare but serious adverse events include pancreatitis (characterised by severe abdominal pain radiating to the back), gallbladder problems, hypoglycaemia when used with other diabetes medications, and allergic reactions [3]. Our superintendent pharmacist Tarun Kumar and the prescribing team provide ongoing monitoring and can adjust treatment plans as needed to maximise tolerability.

Why Choose Cured Pharmacy for Mounjaro Hove Services

Cured Pharmacy serves Mounjaro Hove patients with a fully registered UK online service (GPhC 9012511), ensuring compliance with all MHRA and GPhC regulations. We supply only genuine, UK-licensed Mounjaro manufactured by Eli Lilly, with full traceability and cold-chain integrity maintained throughout storage and dispatch. Our clinical team includes experienced UK-registered prescribers who specialise in weight management and metabolic health.

Hove residents benefit from our commitment to transparent pricing, rapid consultation turnaround, discreet next-day delivery, and ongoing clinical support without additional fees. We never share your data with third parties, and all consultations are conducted in strict confidence. With thousands of successful weight loss journeys facilitated, Cured Pharmacy combines clinical expertise, regulatory compliance, and patient-centred care to deliver the best Mounjaro Hove experience available.

Getting Started with Mounjaro Hove Treatment

Beginning your Mounjaro Hove prescription journey is straightforward. Complete our free three-minute online consultation, which covers your medical history, weight loss goals, and suitability for tirzepatide. If approved by our UK prescriber, your medication is dispatched immediately with tracked delivery to your Hove address. Our team remains available via phone (+44 116 4646009) or email for any questions throughout your treatment, ensuring you feel supported every step of the way.

Scientific References

1. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 30 September 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-218. [accessed 30 September 2026]
3. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Medicines.org.uk. [accessed 30 September 2026]
4. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating type 2 diabetes [TA924]. NICE guidance. [accessed 30 September 2026]
5. Rosenstock, J., Wysham, C., Frías, J. P., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143-155. [accessed 30 September 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 30 September 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 30 September 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 30 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.